â??EFFECTS OF PERIODONTAL THERAPY IN PATIENTS WITH TYPE II DIABETETS MELLITUS AND CHRONIC PERIODONTITISâ??
- Conditions
- Health Condition 1: null- Patients with type II diabetes mellitus and chronic periodontitis
- Registration Number
- CTRI/2013/10/004051
- Lead Sponsor
- Dr Jerry Mammen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 40
1. Patients with age group between 30 to 50.
2. Minimum of 20 teeth present.
3. Patients who were diagnosed with severe periodontitis chronic periodontitis (CDC criteria moderate periodontitis is defind as >=2 interproximal sites with >= 4mm clinical attacment loss (CAL) not on same tooth,or >=2 interproximal with probing depth (PD) >= 5mm not on same tooth severe periodontitis is defind as >=2 teeth with clinical attachment loss >=6mm not on same tooth and >=1 interproximal site with probing depth >= 5mm).
4. Patients diagnosed with type II diabetes mellitus(moderately poor glycemic control, HbA1c between7% and 10%), on oral hypoglycemic drugs and dietary modification only
1.Patients with known systemic disease and condition, other than type II diabetes mellitus such as CVD, renal disease, RA, , liver and pancreatic disease, nutritional deficiencies, pregnant and lactating mother.
2. Patients with acute condition that contraindicate a periodontal examination.
3. Patients who received systemic antibiotic therapy within past 6 month.
4. Patients who received periodontal therapy (scaling and root planing or surgery) past 1 year.
5. Smokers and smokeless tobacco users
6. Patients not willing to sign informed consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method insulin resistanceTimepoint: three months
- Secondary Outcome Measures
Name Time Method Glycemic control <br/ ><br> <br/ ><br>Timepoint: three months